Device-Specific Outcomes of Percutaneous Mechanical Aspiration in Righ… sciencedirect.com/science/ar… 🫀 Thank you @aelsab #CLEAR-IE. @MayoClinicINFD @MayoClinicCV @MayoClinicCVS

@aelsab with a superb case showing treatment of cardiac mass percutaneously. He has published the largest case series in endocarditis and is one of the foremost experts in the world in this arena @mirvatalasnag @AlkashkariWail @drptca @kfaraidy @crfheart

@crfheart ICOACH session covering transcatheter management of intracardiac masses Chair @aelsab Operator @MohamedEmad94 Imaging @mohamed_elsabah @ChamsiPash Panel @BatoolAbuhalim1 @BinAbdulHak_A @MuathRabee @MohammedQintar

At #TCTMiddleEast2026, the diversity of our faculty is not just unique — it is unprecedented.

The TCT Middle East family brings you a unique iCOACH session of TAV in SAV with Basilica These are unique sessions designed by @crfheart for a skill based field Chair @drptca @kalazizimd Operator @AnasNomanMD CT analysis @ChamsiPash White board @6ayyeboon Echo analysis @YaserNemshah Panel @HindAlosaimi_ @abdulaziz_radhi @Uthman_Aluthman #Simulands @PhilipsME

The Rise of the Solo TAVR Operator: Alone, Unarmed, and Unafraid sciencedirect.com/science/ar… Written before CMS finalized its new TAVR NCD - I think CMS got some of it right, and one big thing wrong. Braasch et al looked at 400K Medicare TAVRs, 2016 to 2024. Surgical bailout in 0.56%, falling from 0.92% to 0.40%. Hospital SAVR volume, whether low, intermediate, or high, was not associated with mortality among patients requiring salvage surgery. The absence of an on-site surgeon is not the absence of rescue. Transfer systems exist. A growing share of catastrophic complications, including contained annular injury, tamponade, and device embolization, are now rescued in the cath lab, far from the OR. We have run this experiment before - PCI required on-site surgery on the same theory. CPORT-E: over 18k patients, 6-week mortality 0.9% vs 0.8%. MASS COMM: emergency surgery in 0.1% to 0.3%. PCI without on-site surgery became standard. Systems of care exists across the spectrum of CV care: cardiogenic shock, PE care etc. What CMS got right in the final NCD: TAVR may be performed by a single operator. The mandated dual-specialty evaluation is dropped and only the operator's visit is required. Hospital procedural volume requirements are removed. Asymptomatic severe AS is now covered under CED. Where CMS got it wrong: on-site cardiac surgery is retained. It compels the backup that is so rarely needed. A system of care with straightforward TAVRs being performed by ICs in non-surgical sites with affiliations for complex/transfers would've balanced access. However, CMS & cardiac societies chose politics over patients in the end. Proof: no requirement for on-site EP, though permanent pacing is the most common service after TAVR. No requirement for vascular surgery - much more valuable to a TAVR operator than CV surgery. The mandate is kept to protect physicians not patients. Morevover, medicare imposes no minimum-volume condition on SAVR, despite a median annual surgeon volume of 16 cases. Volume, staffing and heart team requirements get framed as safeguards of quality. But they are absent for the surgical equivalent. Let's be honest - that framing is a pretext for protecting case volume, referral patterns, and established programs. Legitimate interests, just not the ones a public payer is charged with protecting. CMS exists to serve beneficiaries. Its mandate is to protect patients, not programs or professions. Where a requirement principally constrains competition, restricts access, or entrenches incumbents without corresponding patient benefit, it should be removed. Politics over patients. The solo TAVR operator is not a threat to patients. It is the means of reaching them. Hardly unarmed: percutaneous rescue, disciplined case selection, a defined transfer network. CMS came some of the way. They didn't have the courage to do the right thing and patients will pay the price. doi.org/10.1016/j.jcin.2026.… @JACCJournals @SCAI @ACCinTouch @TCTMD @CRFheart @STS_CTsurgery @MayoClinicCV @rajivxgulati @SVRaoMD @drroxmehran @AjayKirtaneMD @mmamas1973 @rwyeh @adnanalkhouli @mirvatalasnag @jaygirimd @tjsimard @PietroDiSantoMD @OmarARazek @mandeep_mayo @willsuh76 @EleidMack @ChetRihal @MayraGuerreroMD @AbdullahAlabcha @aelsab @evandrofilhobr @Mahmoud_Ismayl @lamelaspablo #TAVR #TAVI

iCOACH — Transcatheter Treatment of Cardiac Masses A novel and rapidly evolving frontier in interventional cardiology. From thrombus to vegetations — how do we treat cardiac masses without surgery? 📅 Saturday, 19th September 2026 | 10:05 - 11:05 📍 Riyadh Arena | Ballroom A | Level 3 📍 JW Marriott Hotel Riyadh | SEPTEMBER 17-19, 2026 🏅 24 CME ACCREDITED Honored to share the stage with an exceptional faculty: Moderators: Ali O. AbuAlSaud, Abdallah El Sabbagh Discussants: Batool Jamal Abuhalimeh, Aref Bin Abdulhak, Mohamed Ali Elsabah, Muath Rabee, Sameh Sayfo Modern Toolbox for Percutaneous Treatment of Cardiac Masses: Mohammed Qintar Case-in-a-Box: Abdallah El Sabbagh Simulation: Mohammed Al Hijji Imaging: TEE, ICE & CT: Mohammed Chamsi-Pasha Whiteboard Analyst: Mohamed Ali Elsabah Join us for a highly interactive, case-based, and practical session that will change your toolbox for cardiac masses. See you in Riyadh! #TCTMiddleEast2026

iCOACH — Transcatheter Treatment of Cardiac Masses! 🫀 Join us at #TCTMiddleEast2026 for a dedicated iCOACH session on the transcatheter treatment of cardiac masses. Follow the session alongside leading experts as they explore the modern toolbox for percutaneous treatment of cardiac masses through case-in-a-box, simulation, and imaging with TEE, ICE, and CT. 📅 Saturday, September 19, 2026 I ⏰ 10:05–11:05 📍 Riyadh Arena | Ballroom A | Level 3 | JW Marriott Hotel Riyadh Register Now: tctplusme.com/register Website: tctplusme.com Cardiovascular Research Foundation Transcatheter Cardiovascular Therapeutics (TCT) #cardiology #interventionalcardiology

Infective Endocarditis: Diagnosis, Antibiotic Therapy, and Management: A Scientific Statement From the American Heart Association | Circulation ahajournals.org/doi/10.1161/… ❤️‍🔥 Congratulations Dan and colleagues. #AHA @MayoClinicINFD @MayoClinicCV

@crfheart prides itself on novel educational tools 🛠️ iCOACH sessions with simulation are part of a comprehensive & unique program developed specifically for an operator based learning experience 🛠️The heart team is integral to these well rehearsed activities @jgranadacrf @djc795 @mmamas1973 @mirvatalasnag @Drroxmehran @AnasNomanMD @MarwanSaadMD @abdulaziz_radhi @AlkashkariWail @DrAlbinmousa @amrmohsen213 @aelsab

Faculty are conducting preparatory calls to ensure a top of the line educational program Brace yourselves for the 2nd iteration of #TCTPlusMiddleEast @crfheart @jgranadacrf @drptca @kfaraidy @mmamas1973 @AlkashkariWail @mirvatalasnag @MohammedQintar @aelsab @adnanalkhouli @RHAAttar @AlrahimiJ et al 🥁🥁

We’re pleased to announce Dr. Mohamad Alkhouli (@adnanalkhouli) as the next editor-in-chief of #JACCINT. He brings global expertise in interventional cardiology, CV research, and 10+ years of editorial leadership. 👏👏👏 Learn more about him here: bit.ly/4gItbFi

Building on last year’s momentum 🥁🥁🥁 @mohamed_elsabah you can’t hide..we can always dig out your pic 📸 😁😇

The spectrum of live cases will cover coronary & structural procedures relevant to the whole team: clinicians, surgeons, operators & imagers #LetTheLearningBegin @crfheart @ASE360 @Heart_SCCT @jgranadacrf @AlkashkariWail @drptca @mmamas1973 @mirvatalasnag

RT @MaryHedgesMD: Humble brag moment when the TEAM makes this possible: Doximity rankings of #1 IM residency in Florida, and Top FIVE in in…

I will forever be grateful to the @ACCinTouch for welcoming into the cardiology community and making me feel at home and with a strong sense of belonging. Every year there are new opportunities and I meet more wonderful individuals willing to mentor and support my process and hundreds of other trainees and early career. I love this community @EugeniaGianos @DrMichaelShapir @russcolombomd @khurramn1 @MelvinEchols9 @HFnursemaghee @DrQuinnCapers4 @mmartinezheart @drdavemd @dkenigsberg @FloridaACC @aelsab @PrajReddyMD @rblument1

Announcing soon: Shortlist for the Shark Tank 🦈 TCT Middle East Innovation Competition 💰💰200,000 💰💰 Generously supported by @JHopkinsSaudi @crfheart @TCTConference @jgranadacrf @Drroxmehran @kfaraidy @drptca @AlkashkariWail @mirvatalasnag @mmamas1973 @AdelTash @halfaleh @adnanalkhouli @FogartyInnov @KAUST_News @atherosociety @Heart_SCCT @ASE360 @medshronline @CN_publishing @CardioBusiness

Catheter-based mechanical aspiration has emerged as a percutaneous strategy for vegetation debulking in select patients with right-sided infective endocarditis. The role of percutaneous mechanical aspiration in left-sided infective endocarditis, however, remains uncertain. In this analysis from the CLEAR-IE registry, the authors report on the feasibility and safety of percutaneous mechanical aspiration in 30 patients from 9 US centers. eurointervention.pcronline.c…

We’re honored to announce the keynote speaker for 2026 @Dr_HaniNajm President Elect of @ACCinTouch A journey that took him from KSA & USA…let’s learn about a journey with patents & innovations, education & growth and collaborations & leadership @crfheart @TCTConference @jgranadacrf @Drroxmehran @kfaraidy @mirvatalasnag @AlkashkariWail @drptca @mmamas1973 @AdelTash @abdulaziz_radhi @HindAlosaimi_

In the multicentre CLEAR-IE registry, percutaneous mechanical aspiration for left-sided infective endocarditis was feasible, achieved high procedural success, and showed an acceptable safety profile in a highly complex patient population. Read more here: eurointervention.pcronline.c… @NahyrLugo @benhibbertMDPhD @PedroMDMSc @SripalBangalore @MohammedQintar @SEH_MD @psorajja @HamidNadira @PradeepYadavMD @sahilparikhmd @aelsab